Drug intelligence / Profile preview

schisandrin A

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Schisandrin A is a natural dibenzocyclooctadiene lignan and one of the major bioactive components isolated from the fruit of Schisandra chinensis. It exhibits multiple pharmacological activities including antioxidant, anti-inflammatory, neuroprotective, hepatoprotective, anticancer, and anti-diabetic effects. Mechanistically, schisandrin A modulates oxidative stress by enhancing antioxidant enzymes and reducing reactive oxygen species. It exerts anti-inflammatory action by inhibiting production of pro-inflammatory cytokines and modulating signaling pathways such as the NF-κB pathway. In neurological models, it crosses the blood-brain barrier and protects neurons by reducing glutamate-induced cytotoxicity, oxidative stress, and apoptosis. In preclinical studies, it also shows protective effects in models of liver disease, cardiovascular disease, and metabolic syndrome. Its molecular formula is C24H32O6 and it is used predominantly in research settings as a purified phytochemical derived from S. chinensis[3][4][8][12][13].

Brand names
五酯胶囊
Other names
schisandrin A(+)-schizandrinschisandrinewuweizi alcohol A
02

Targets

GST (Glutathione S-transferase alpha 3)

Beyond the preview

Go deeper on schisandrin A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on schisandrin A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call